⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28213190 | 0.97 | — | — | |
| SCHEMBL1995724 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL6888353 | 0.73 | — | — | |
| SCHEMBL27197660 | 0.72 | ADH1B (0.33) | — | |
| SCHEMBL839397 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL28228006 | 0.69 | — | — | |
| SCHEMBL271217 | 0.69 | — | — | |
| SCHEMBL3626775 | 0.68 | LMNA (0.31) | — | |
| SCHEMBL11790131 | 0.68 | — | — | |
| Hydrochloric Acid SCHEMBL28241516 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143408-B2 | N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain | ASTRAZENECA AB (SE) | 2012-03-27 | — | — | US | claimed |
| US-20100137322-A1 | NOVEL N-(8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N-(5-HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2010-06-03 | — | — | US | claimed |
| CN-113874426-B | Water-soluble film and package | 株式会社可乐丽 | 2025-03-28 | — | — | CN | disclosed |
| CN-112147731-B | Optical filter, solid-state imaging device, and camera module | JSR株式会社 | 2023-12-05 | — | — | CN | disclosed |
| CN-111868579-B | Optical filter and use thereof | JSR株式会社 | 2022-08-09 | — | — | CN | disclosed |
| CN-113874426-A | Water-soluble film and package | 株式会社可乐丽 | 2021-12-31 | — | — | CN | disclosed |
| CN-112794788-B | Method for synthesizing fluoroisobutylene by using hexafluoropropylene as starting material | 泉州宇极新材料科技有限公司 | 2021-07-09 | — | — | CN | disclosed |
| CN-112794788-A | Method for synthesizing fluoroisobutylene by using hexafluoropropylene as starting material | 北京宇极科技发展有限公司 | 2021-05-14 | — | — | CN | disclosed |
| CN-112147731-A | Optical filter, solid-state imaging device, camera module, biometric authentication device, and resin layer for optical filter | JSR株式会社 | 2020-12-29 | — | — | CN | disclosed |
| CN-111868579-A | Optical filter and use thereof | JSR株式会社 | 2020-10-30 | — | — | CN | disclosed |
| WO-2020218321-A1 | WATER-SOLUBLE FILM AND PACKAGING | 株式会社クラレ | 2020-10-29 | — | — | WO | disclosed |
| WO-2004065391-A1 | 4-AMINOTHIENO[2,3-d]PYRIMIDINE-6-CARBONITRILE DERIVATIVES AS PDE7 INHIBITORS | ALMIRALL PRODESFARMA S.A. (ES) | 2004-08-05 | — | — | WO | disclosed |
| WO-2004058729-A1 | NEW PYRIDAZIN-3(2H)-ONE DERIVATIVES | ALMIRALL PRODESFARMA SA (ES) | 2004-07-15 | — | — | WO | disclosed |
| WO-2004043966-A1 | NEW TRICYCLIC DERIVATIVES AS LTD4 ANTAGONISTS | ALMIRALL PRODESFARMA S.A. (ES) | 2004-05-27 | — | — | WO | disclosed |
| CN-1477995-A | Fluorinated zwitterionic cocatalyst activators for olefin polymerization | 埃克森美孚化学专利公司 | 2004-02-25 | — | — | CN | disclosed |
| EP-0819000-A4 | NODULISPORIC ACID DERIVATIVES | MERCK & CO INC (US) | 2001-04-11 | — | — | EP | disclosed |
| US-5962499-A | ACARICIDAL, ANTIPARASITIC, INSECTICIDAL AND ANTHELMINTIC AGENTS | MERCK & CO., INC. (US) | 1999-10-05 | — | — | US | disclosed |
| EP-0819000-A1 | NODULISPORIC ACID DERIVATIVES | Merck & Co., Inc. (US) | 1998-01-21 | — | — | EP | disclosed |
| WO-1996029073-A1 | NODULISPORIC ACID DERIVATIVES | MERCK & CO., INC. (US) | 1996-09-26 | — | — | WO | disclosed |
| WO-1995006642-A1 | MALODINITRIL-SUBSTITUTED 1,3,5-TRIAZIN-DIAMINES WITH HERBICIDAL ACTIVITY | BAYER AKTIENGESELLSCHAFT (DE) | 1995-03-09 | — | — | WO | disclosed |